Kodiak Sciences Inc
(NASDAQ:KOD)
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
top performing KOD trades
-31.10%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Kodiak Sciences trades made by congress members.
Chris JacobsHouse (R-NY) | $1K - $15K | stock | Sale | Dec 12, 2022 | Nov 08, 2022 | House |
Chris JacobsHouse (R-NY) | $1K - $15K | stock | Purchase | Sep 09, 2022 | Jul 18, 2022 | House |